target_chembl_id,target_organism,document_journal,document_year,activity_id,standard_type,molecule_pref_name,target_pref_name,assay_chembl_id,bao_format,pchembl_value,assay_description
CHEMBL612545,None,J. Med. Chem.,2010,3120511,Ki,VANIPREVIR,Unchecked,CHEMBL1073033,BAO_0000019,10.3,Inhibition of HCV1b BK full length NS3/4A protease expressed in Escherichia coli after 1 hr by time-resolved fluorescence assay
CHEMBL612545,None,J. Med. Chem.,2010,3120525,Ki,VANIPREVIR,Unchecked,CHEMBL1073034,BAO_0000019,9.05,Inhibition of HCV JFH-1 full length NS3/4A protease expressed in Escherichia coli after 1 hr by time-resolved fluorescence assay
CHEMBL379,Hepatitis C virus,J. Med. Chem.,2010,3120535,IC50,VANIPREVIR,Hepatitis C virus,CHEMBL1073035,BAO_0000218,8.52,Antiviral activity against HCV Con1 infected in human HuH7 cells assessed as inhibition of viral replication after 24 hrs by replicon assay in presence of 10% fetal bovine serum
CHEMBL379,Hepatitis C virus,J. Med. Chem.,2010,3120545,IC50,VANIPREVIR,Hepatitis C virus,CHEMBL1064411,BAO_0000218,8.05,Antiviral activity against HCV JFH-1 infected in human HuH7 cells assessed as inhibition of viral replication after 24 hrs by replicon assay in presence of 10% fetal bovine serum
CHEMBL379,Hepatitis C virus,J. Med. Chem.,2010,3120553,IC50,VANIPREVIR,Hepatitis C virus,CHEMBL1064409,BAO_0000218,7.72,Antiviral activity against HCV Con1 infected in human HuH7 cells assessed as inhibition of viral replication after 24 hrs by replicon assay in presence of 50% normal human serum
CHEMBL612545,None,Bioorg. Med. Chem.,2010,3370820,Ki,VANIPREVIR,Unchecked,CHEMBL1177147,BAO_0000019,10.22,Inhibition of HCV NS3 protease by FRET assay
CHEMBL379,Hepatitis C virus,Bioorg. Med. Chem.,2010,3370840,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1177148,BAO_0000218,8.3,Antiviral activity against HCV 1B infected in human Huh7 cells by firefly luciferase reporter gene assay
CHEMBL612545,None,Antimicrob. Agents Chemother.,2010,3450446,IC50,VANIPREVIR,Unchecked,CHEMBL1245069,BAO_0000019,6.28,Inhibition of human Chymotrypsin
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450448,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245070,BAO_0000218,6.37,Antiviral activity against Hepatitis C virus containing NS3/D168Y protease mutant activity by TaqMan-based assay
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450450,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245072,BAO_0000218,6.46,Antiviral activity against Hepatitis C virus containing NS3/R155K protease mutant activity by TaqMan-based assay
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450452,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245071,BAO_0000218,6.7,Antiviral activity against Hepatitis C virus containing NS3/A156T protease mutant activity by TaqMan-based assay
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450462,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245061,BAO_0000218,7.57,Antiviral activity against Hepatitis C virus containing NS3/4a ps30 sequence by transient cell-base protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450467,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245113,BAO_0000218,7.72,Antiviral activity against Hepatitis C virus containing NS3/4a ps41 sequence by transient cell-base protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450469,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245077,BAO_0000218,7.82,Antiviral activity against Hepatitis C virus genotype 2a infected in mouse HB1 cell by cell-based HCV replicon assay in presence of 10% fetal bovine serum
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450470,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245078,BAO_0000218,7.89,Antiviral activity against Hepatitis C virus genotype 1b infected in mouse HB1 cell by cell-based HCV replicon assay in presence of 50% normal human serum
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450471,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245064,BAO_0000218,8.02,Antiviral activity against Hepatitis C virus containing NS3/4a ps33 sequence by transient cell-base protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450472,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245073,BAO_0000218,8.11,Antiviral activity against Hepatitis C virus containing NS3/F43S protease mutant activity by TaqMan-based assay
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450474,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245110,BAO_0000218,8.19,Antiviral activity against Hepatitis C virus containing NS3/4a ps37 sequence by transient cell-base protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450475,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245111,BAO_0000218,8.22,Antiviral activity against Hepatitis C virus containing NS3/4a ps38 sequence by transient cell-base protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450476,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245074,BAO_0000218,8.28,Antiviral activity against Hepatitis C virus containing NS3/Q41R protease mutant activity by TaqMan-based assay
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450477,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245079,BAO_0000218,8.3,Antiviral activity against Hepatitis C virus genotype 1b infected in mouse HB1 cell by cell-based HCV replicon assay in presence of 10% fetal bovine serum
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450478,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245109,BAO_0000218,8.31,Antiviral activity against Hepatitis C virus containing NS3/4a ps36 sequence by transient cell-base protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450479,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245059,BAO_0000218,8.35,Antiviral activity against Hepatitis C virus containing NS3/4a H77 sequence by transient cell-base protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450480,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245058,BAO_0000218,8.39,Antiviral activity against Hepatitis C virus containing NS3/4a Con1 sequence by transient cell-base protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450481,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245063,BAO_0000218,8.42,Antiviral activity against Hepatitis C virus containing NS3/4a ps32 sequence by transient cell-base protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450482,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245062,BAO_0000218,8.47,Antiviral activity against Hepatitis C virus containing NS3/4a ps31 sequence by transient cell-base protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450484,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245112,BAO_0000218,8.54,Antiviral activity against Hepatitis C virus containing NS3/4a ps40 sequence by transient cell-base protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450485,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245060,BAO_0000218,8.54,Antiviral activity against Hepatitis C virus containing NS3/4a ps20 sequence by transient cell-base protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450486,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1245075,BAO_0000218,8.8,Antiviral activity against Hepatitis C virus genotype 1a containing NS3/con1 protease mutant by TaqMan-based assay
CHEMBL612545,None,Antimicrob. Agents Chemother.,2010,3450487,Ki,VANIPREVIR,Unchecked,CHEMBL1245080,BAO_0000019,8.85,Inhibition of Hepatitis C virus genotype 2b NS3/4A protease activity
CHEMBL612545,None,Antimicrob. Agents Chemother.,2010,3450488,Ki,VANIPREVIR,Unchecked,CHEMBL1245081,BAO_0000019,9.0,Inhibition of Hepatitis C virus genotype 2a NS3/4A protease activity
CHEMBL612545,None,Antimicrob. Agents Chemother.,2010,3450491,Ki,VANIPREVIR,Unchecked,CHEMBL1245083,BAO_0000019,10.15,Inhibition of Hepatitis C virus genotype 1a NS3/4A protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,3450492,Ki,VANIPREVIR,Hepatitis C virus,CHEMBL1245082,BAO_0000218,10.22,Inhibition of Hepatitis C virus genotype 1b NS3/4A protease activity
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,5296271,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1691140,BAO_0000218,9.39,Antiviral activity against HCV1b harboring Q80K polymorphism in NS3 protease gene infected in human Huh7/Lunet cells assessed as inhibition of viral replication after 3 days by luciferase based transient-transfection assay
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,5296276,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1691139,BAO_0000218,9.57,Antiviral activity against HCV1b harboring Q80Q polymorphism in NS3 protease gene infected in human Huh7/Lunet cells assessed as inhibition of viral replication after 3 days by luciferase based transient-transfection assay
CHEMBL379,Hepatitis C virus,Antimicrob. Agents Chemother.,2010,5296282,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL1691136,BAO_0000218,9.15,Antiviral activity against HCV1b Con1 harboring NS3 protease gene infected in human Huh7/Lunet cells assessed as inhibition of viral replication after 3 days by luciferase based transient-transfection assay
CHEMBL379,Hepatitis C virus,J. Med. Chem.,2012,10904000,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL2039935,BAO_0000218,8.8,Antiviral activity against wild type Hepatitis C virus subtype 1b by transient replicon assay
CHEMBL379,Hepatitis C virus,J. Med. Chem.,2012,10904001,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL2039933,BAO_0000218,6.7,Antiviral activity against Hepatitis C virus subtype 1b harboring protease A156T mutant by transient replicon assay
CHEMBL379,Hepatitis C virus,J. Med. Chem.,2012,10904002,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL2039936,BAO_0000218,6.46,Antiviral activity against Hepatitis C virus subtype 1b harboring protease R155K mutant by transient replicon assay
CHEMBL612545,None,ACS Med. Chem. Lett.,2012,10978334,Ki,VANIPREVIR,Unchecked,CHEMBL2065351,BAO_0000019,10.3,Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease expressed in Escherichia coli by time-resolved fluorescence analysis
CHEMBL612545,None,ACS Med. Chem. Lett.,2012,10978349,Ki,VANIPREVIR,Unchecked,CHEMBL2065352,BAO_0000019,7.27,Inhibition of Hepatitis C virus (isolate NZL1) genotype 3a NS3/4a protease expressed in Escherichia coli by time-resolved fluorescence analysis
CHEMBL612545,None,ACS Med. Chem. Lett.,2012,10978372,Ki,VANIPREVIR,Unchecked,CHEMBL2065354,BAO_0000019,7.72,Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease R155K mutant expressed in Escherichia coli by time-resolved fluorescence analysis
CHEMBL612545,None,ACS Med. Chem. Lett.,2012,10978380,Ki,VANIPREVIR,Unchecked,CHEMBL2065355,BAO_0000019,7.66,Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease A156T mutant expressed in Escherichia coli by time-resolved fluorescence analysis
CHEMBL612545,None,ACS Med. Chem. Lett.,2012,10979601,Ki,VANIPREVIR,Unchecked,CHEMBL2065356,BAO_0000019,7.06,Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease A156V mutant expressed in Escherichia coli by time-resolved fluorescence analysis
CHEMBL612545,None,ACS Med. Chem. Lett.,2012,10979609,Ki,VANIPREVIR,Unchecked,CHEMBL2065357,BAO_0000019,7.11,Inhibition of Hepatitis C virus (isolate BK) genotype 1b NS3/4a protease D168V mutant expressed in Escherichia coli by time-resolved fluorescence analysis
CHEMBL379,Hepatitis C virus,ACS Med. Chem. Lett.,2012,10979633,IC50,VANIPREVIR,Hepatitis C virus,CHEMBL2065365,BAO_0000218,7.72,Antiviral activity against Hepatitis C virus (isolate Con1) genotype 1b infected in human HuH7 cells assessed as inhibition of viral replication after 24 hrs in presence of 50% NHS
CHEMBL612545,None,Bioorg. Med. Chem. Lett.,2012,12169440,Ki,VANIPREVIR,Unchecked,CHEMBL2211165,BAO_0000019,7.27,Inhibition of HCV3a NS3/4A protease
CHEMBL2954,Homo sapiens,Bioorg. Med. Chem. Lett.,2013,13501499,IC50,VANIPREVIR,Cathepsin S,CHEMBL2446012,BAO_0000357,4.11,Inhibition of human cathepsin S
CHEMBL379,Hepatitis C virus,Bioorg. Med. Chem. Lett.,2013,13501535,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL2446528,BAO_0000218,5.62,Inhibition of Hepatitis C virus genotype 1b NS3/4A protease D168A mutant
CHEMBL379,Hepatitis C virus,Bioorg. Med. Chem. Lett.,2013,13501547,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL2446019,BAO_0000218,8.34,Inhibition of Hepatitis C virus genotype 1b NS3/4A protease V170A mutant
CHEMBL379,Hepatitis C virus,Bioorg. Med. Chem. Lett.,2013,13501571,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL2446025,BAO_0000218,7.35,Inhibition of Hepatitis C virus genotype 1b NS3/4A protease V36M mutant
CHEMBL379,Hepatitis C virus,Bioorg. Med. Chem. Lett.,2013,13501607,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL2446533,BAO_0000218,6.04,Inhibition of Hepatitis C virus genotype 1b NS3/4A protease A156T mutant
CHEMBL379,Hepatitis C virus,Bioorg. Med. Chem. Lett.,2013,13501611,EC50,VANIPREVIR,Hepatitis C virus,CHEMBL2446534,BAO_0000218,8.21,Inhibition of Hepatitis C virus genotype 1b wild type NS3/4A protease
CHEMBL3559639,Hepatitis C virus,Bioorg. Med. Chem.,2014,14984773,Ki,VANIPREVIR,Nonstructural protein NS3-4A,CHEMBL3384808,BAO_0000357,10.3,Inhibition of HCV genotype 1a NS3/4A protease using Ac-DED(Edans)EEAbu-psi[COO]ASK(Dabcyl)-NH2 as substrate by FRET assay
CHEMBL3879801,None,Bioorg. Med. Chem.,2014,14984807,EC50,VANIPREVIR,NON-PROTEIN TARGET,CHEMBL3384817,BAO_0000019,8.3,Antiviral activity against HCV genotype 1a
